| 1 | Mortality in men with castration‐resistant prostate cancer—A long‐term follow‐up of a population‐based real‐world cohort | BJUI Compass | 2022 | 33 |
| 2 | Transition zone prostate cancer is associated with better clinical outcomes than peripheral zone cancer | BJUI Compass | 2021 | 29 |
| 3 | Ductal adenocarcinoma of the prostate: A systematic review and meta‐analysis of incidence, presentation, prognosis, and management | BJUI Compass | 2021 | 29 |
| 4 | Optilume drug‐coated balloon for anterior urethral stricture: 2‐year results of the ROBUST III trial | BJUI Compass | 2024 | 29 |
| 5 | Development and validation of a novel multivariate risk score to guide biopsy decision for the diagnosis of clinically significant prostate cancer | BJUI Compass | 2020 | 28 |
| 6 | Surgical robotic systems: What we have now? A urological perspective | BJUI Compass | 2020 | 27 |
| 7 | A multi‐institutional randomized controlled trial comparing first‐generation transrectal high‐resolution micro‐ultrasound with conventional frequency transrectal ultrasound for prostate biopsy | BJUI Compass | 2021 | 27 |
| 8 | Aquablation therapy in large prostates (80–150 cc) for lower urinary tract symptoms due to benign prostatic hyperplasia: WATER II 3‐year trial results | BJUI Compass | 2022 | 27 |
| 9 | Suction use in ureterorenoscopy: A systematic review and meta‐analysis of comparative studies | BJUI Compass | 2024 | 27 |
| 10 | Selection of patients for nerve sparing surgery in robot‐assisted radical prostatectomy | BJUI Compass | 2022 | 25 |
| 11 | Systematic review of complications arising from male circumcision | BJUI Compass | 2022 | 25 |
| 12 | Robotic retroperitoneal lymph node dissection for testicular cancer at a national referral centre | BJUI Compass | 2022 | 22 |
| 13 | Fluoroquinolone resistance in urinary tract infections: Epidemiology, mechanisms of action and management strategies | BJUI Compass | 2024 | 22 |
| 14 | Accuracy of prostate cancer screening recommendations for high‐risk populations on YouTube and TikTok | BJUI Compass | 2023 | 21 |
| 15 | Genomic alterations in neuroendocrine prostate cancer: A systematic review and meta‐analysis | BJUI Compass | 2023 | 21 |
| 16 | Outcomes of organ‐sparing surgery for adult testicular tumors: A systematic review of the literature | BJUI Compass | 2021 | 20 |
| 17 | Local versus general anesthesia transperineal prostate biopsy: Tolerability, cancer detection, and complications | BJUI Compass | 2021 | 20 |
| 18 | The role of URO17™ biomarker to enhance diagnosis of urothelial cancer in new hematuria patients—First European Data | BJUI Compass | 2021 | 19 |
| 19 | Quality and readability of online patient information on treatment for erectile dysfunction | BJUI Compass | 2021 | 18 |
| 20 | Prognostic impact of proton pump inhibitors for immunotherapy in advanced urothelial carcinoma | BJUI Compass | 2022 | 18 |
| 21 | Enhanced recovery after surgery review and urology applications in 2020 | BJUI Compass | 2020 | 15 |
| 22 | Radical Cystectomy in England from 2013 to 2019 on 12,644 patients: An analysis of national trends and comparison of surgical approaches using Hospital Episode Statistics data | BJUI Compass | 2021 | 15 |
| 23 | Does a screening digital rectal exam provide actionable clinical utility in patients with an elevated PSA and positive MRI? | BJUI Compass | 2021 | 15 |
| 24 | Potential effectiveness of local radiotherapy for extending survival and reducing symptomatic local events in patients with de novo metastatic prostate cancer | BJUI Compass | 2020 | 14 |
| 25 | Effect of microsurgical varicocelectomy on semen parameters, serum, and intratesticular testosterone levels | BJUI Compass | 2020 | 14 |
| 26 | Long‐term outcomes of outpatient laser ablation for recurrent non‐muscle invasive bladder cancer: A retrospective cohort study | BJUI Compass | 2022 | 14 |
| 27 | Urology consultants versus large language models: Potentials and hazards for medical advice in urology | BJUI Compass | 2024 | 14 |
| 28 | Systematic expression analysis of m6A RNA methyltransferases in clear cell renal cell carcinoma | BJUI Compass | 2021 | 13 |
| 29 | Female sexual function in bladder cancer: A review of the evidence | BJUI Compass | 2023 | 13 |
| 30 | Robotic‐assisted versus laparoscopic nephroureterectomy; a systematic review and meta‐analysis | BJUI Compass | 2023 | 13 |
| 31 | Single use flexible ureteroscopes: Current status and future directions | BJUI Compass | 2023 | 13 |
| 32 | Intravesical gemcitabine as bladder‐preserving treatment for BCG unresponsive non‐muscle‐invasive bladder cancer. Results from a single‐arm, open‐label study | BJUI Compass | 2020 | 12 |
| 33 | Orthotopic bladder substitution: Surgical aspects and optimization of outcomes | BJUI Compass | 2021 | 12 |
| 34 | Impact of perioperative factors on nadir serum prostate‐specific antigen levels after holmium laser enucleation of prostate | BJUI Compass | 2021 | 12 |
| 35 | Comparing outcomes of transperineal to transrectal prostate biopsies performed under local anaesthesia | BJUI Compass | 2022 | 12 |
| 36 | Real‐world first‐line systemic therapy patterns in metastatic castration‐resistant prostate cancer | BJUI Compass | 2022 | 12 |
| 37 | Robotic ureteral reconstruction for recurrent strictures after prior failed management | BJUI Compass | 2023 | 12 |
| 38 | Robot‐assisted laparoscopic augmentation ileocystoplasty and Mitrofanoff appendicovesicostomy in children: Step‐by‐step and modifications to UChicago technique | BJUI Compass | 2020 | 11 |
| 39 | The diagnostic accuracy of multiparametric MRI for detection and localization of prostate cancer depends on the affected region | BJUI Compass | 2021 | 11 |
| 40 | Systematic review of the association between socioeconomic status and bladder cancer survival with hospital type, comorbidities, and treatment delay as mediators | BJUI Compass | 2021 | 11 |
| 41 | Pharmacological and interventional treatment of benign prostatic obstruction: An evidence‐based comparative review | BJUI Compass | 2021 | 11 |
| 42 | Prognostic impact of eligibility for adjuvant immunotherapy in locally advanced urothelial cancer | BJUI Compass | 2022 | 11 |
| 43 | Pure single‐port retzius‐sparing robot‐assisted radical prostatectomy with the da Vinci SP: Initial experience and technique description | BJUI Compass | 2022 | 11 |
| 44 | The Recurrent Urinary Tract Infection Symptom Scale: Development and validation of a patient‐reported outcome measure | BJUI Compass | 2023 | 11 |
| 45 | A prospective study on single‐port versus multiport patient‐reported surgical outcomes | BJUI Compass | 2024 | 11 |
| 46 | Frailty is a predictor of moderate to severe pain after robot‐assisted laparoscopic prostatectomy: A case‐control study (FRAP study) | BJUI Compass | 2020 | 10 |
| 47 | Prognostic value of automated bone scan index for predicting overall survival among bone metastatic castration resistant prostate cancer patients treated with radium‐223 | BJUI Compass | 2021 | 10 |
| 48 | M1a prostate cancer: Results of a Dutch multidisciplinary consensus meeting | BJUI Compass | 2021 | 10 |
| 49 | Surgical innovation revisited: A historical narrative of the minimally invasive “Agarwal sliding‐clip renorrhaphy” technique for partial nephrectomy and its application to an Australian cohort | BJUI Compass | 2021 | 10 |
| 50 | FGFR2/3 genomic alterations and response to Enfortumab Vedotin in metastatic urothelial carcinoma | BJUI Compass | 2022 | 10 |